21shares Dogecoin ETF (TDOG)

Looking at the 10-Q filing data on our desk, TDOG's net asset value has cratered by 43.37% since its January launch, sitting at $14.53 as of late June 2026. While it offers a transparent grantor trust structure holding over 38 million physical Dogecoin, the sheer magnitude of unrealized depreciation—totaling nearly $1.5 million in net decreases over nine months—highlights the extreme capital erosion risk for anyone holding this outside a strictly managed speculative allocation.

From a market sentiment perspective, TDOG occupies a fascinating niche as the sole ETF endorsed by the Dogecoin Foundation. However, trading volumes are currently hovering around a modest 3.23K versus a 15.22K average, pointing to muted retail and institutional engagement during this drawdown phase. With a 0.50% unitary Sponsor Fee and net assets lingering around $2.76 million, the fund's long-term commercial viability depends heavily on a broader crypto market recovery to pull its stock price back toward its 52-week high of $25.59.

When evaluating risk protocols for non-40 Act products like TDOG, clinicians and risk managers must emphasize that an investment here is not a direct investment in Dogecoin, nor does it carry the regulatory protections of traditional mutual funds. The fund holds physical DOGE to track the CF Dogecoin-Dollar US Settlement Price Index, but extraordinary expenses can fall on the trust, and investors must be psychologically and financially prepared for the potential loss of their entire principal given the asset's historical volatility.